Propofol versus placebo (with rescue with ketamine) before less invasive surfactant administration: study protocol for a multicenter, double-blind, placebo controlled trial (PROLISA)

Abstract Background One major limitation for less invasive surfactant administration (LISA) is the difficulty in providing sedation before this procedure and the competitive risk of respiratory depression versus avoidance of intubation for most sedative or analgesic drugs used in this context. The o...

Full description

Bibliographic Details
Main Authors: Marie Chevallier, Xavier Durrmeyer, Anne Ego, Thierry Debillon, The PROLISA Study Group
Format: Article
Language:English
Published: BMC 2020-05-01
Series:BMC Pediatrics
Subjects:
Online Access:http://link.springer.com/article/10.1186/s12887-020-02112-x
_version_ 1828781324487360512
author Marie Chevallier
Xavier Durrmeyer
Anne Ego
Thierry Debillon
The PROLISA Study Group
author_facet Marie Chevallier
Xavier Durrmeyer
Anne Ego
Thierry Debillon
The PROLISA Study Group
author_sort Marie Chevallier
collection DOAJ
description Abstract Background One major limitation for less invasive surfactant administration (LISA) is the difficulty in providing sedation before this procedure and the competitive risk of respiratory depression versus avoidance of intubation for most sedative or analgesic drugs used in this context. The objective of this study is to compare the need for mechanical ventilation within 72 h of life following premedication with propofol, versus placebo (rescue with ketamine), for the LISA procedure in preterm neonates born before 32 weeks gestational age (wGA). Methods ProLISA is a phase III, non-inferiority, multicenter, double blind, randomized, placebo controlled trial designed according to the SPIRIT Statement. Neonates born before 32 wGA in 12 geographically dispersed Neonatal Intensive Care Units in France needing surfactant will be included from September 2019 to September 2022. A sample of 542 patients is needed. The neonate is randomized to the intervention (propofol) or control placebo group. Open label rescue treatment with ketamine is possible in both groups if FANS (Faceless Acute Neonatal pain Scale) is ≥6. To guide drug administration, FANS is scored before attempting laryngoscopy. Once an adequate score has been obtained, LISA is performed according to a standardized protocol. The primary outcome is the need for mechanical ventilation within 72 h of life. Secondary outcomes are tolerance of the procedure, pain evaluation, hemodynamic and neurologic parameters after the intervention, morbidities before discharge and neurodevelopmental assessment at 2 years of age. Discussion This paper describes the first multicenter, double-blind, randomized, placebo-controlled trial on this topic and will provide crucial information to support implementation of the LISA procedure. Trial registration ClinicalTrials.gov: NCT04016246 . Registered 06 June 2019, N°EUDRACT: 2018–002876-41.
first_indexed 2024-12-11T17:31:42Z
format Article
id doaj.art-ca7209688503473a8333e928a8b44cde
institution Directory Open Access Journal
issn 1471-2431
language English
last_indexed 2024-12-11T17:31:42Z
publishDate 2020-05-01
publisher BMC
record_format Article
series BMC Pediatrics
spelling doaj.art-ca7209688503473a8333e928a8b44cde2022-12-22T00:56:47ZengBMCBMC Pediatrics1471-24312020-05-012011910.1186/s12887-020-02112-xPropofol versus placebo (with rescue with ketamine) before less invasive surfactant administration: study protocol for a multicenter, double-blind, placebo controlled trial (PROLISA)Marie Chevallier0Xavier Durrmeyer1Anne Ego2Thierry Debillon3The PROLISA Study GroupUMR 5525 ThEMAS, CNRS, TIMC-IMAG, Grenoble Alps UniversityNeonatal Intensive Care Unit, Centre Hospitalier Intercommunal de CréteilNeonatal Intensive Care Unit, Grenoble Alps University HospitalUMR 5525 ThEMAS, CNRS, TIMC-IMAG, Grenoble Alps UniversityAbstract Background One major limitation for less invasive surfactant administration (LISA) is the difficulty in providing sedation before this procedure and the competitive risk of respiratory depression versus avoidance of intubation for most sedative or analgesic drugs used in this context. The objective of this study is to compare the need for mechanical ventilation within 72 h of life following premedication with propofol, versus placebo (rescue with ketamine), for the LISA procedure in preterm neonates born before 32 weeks gestational age (wGA). Methods ProLISA is a phase III, non-inferiority, multicenter, double blind, randomized, placebo controlled trial designed according to the SPIRIT Statement. Neonates born before 32 wGA in 12 geographically dispersed Neonatal Intensive Care Units in France needing surfactant will be included from September 2019 to September 2022. A sample of 542 patients is needed. The neonate is randomized to the intervention (propofol) or control placebo group. Open label rescue treatment with ketamine is possible in both groups if FANS (Faceless Acute Neonatal pain Scale) is ≥6. To guide drug administration, FANS is scored before attempting laryngoscopy. Once an adequate score has been obtained, LISA is performed according to a standardized protocol. The primary outcome is the need for mechanical ventilation within 72 h of life. Secondary outcomes are tolerance of the procedure, pain evaluation, hemodynamic and neurologic parameters after the intervention, morbidities before discharge and neurodevelopmental assessment at 2 years of age. Discussion This paper describes the first multicenter, double-blind, randomized, placebo-controlled trial on this topic and will provide crucial information to support implementation of the LISA procedure. Trial registration ClinicalTrials.gov: NCT04016246 . Registered 06 June 2019, N°EUDRACT: 2018–002876-41.http://link.springer.com/article/10.1186/s12887-020-02112-xLess invasive surfactant administrationSedationPropofolKetamineRandomized study
spellingShingle Marie Chevallier
Xavier Durrmeyer
Anne Ego
Thierry Debillon
The PROLISA Study Group
Propofol versus placebo (with rescue with ketamine) before less invasive surfactant administration: study protocol for a multicenter, double-blind, placebo controlled trial (PROLISA)
BMC Pediatrics
Less invasive surfactant administration
Sedation
Propofol
Ketamine
Randomized study
title Propofol versus placebo (with rescue with ketamine) before less invasive surfactant administration: study protocol for a multicenter, double-blind, placebo controlled trial (PROLISA)
title_full Propofol versus placebo (with rescue with ketamine) before less invasive surfactant administration: study protocol for a multicenter, double-blind, placebo controlled trial (PROLISA)
title_fullStr Propofol versus placebo (with rescue with ketamine) before less invasive surfactant administration: study protocol for a multicenter, double-blind, placebo controlled trial (PROLISA)
title_full_unstemmed Propofol versus placebo (with rescue with ketamine) before less invasive surfactant administration: study protocol for a multicenter, double-blind, placebo controlled trial (PROLISA)
title_short Propofol versus placebo (with rescue with ketamine) before less invasive surfactant administration: study protocol for a multicenter, double-blind, placebo controlled trial (PROLISA)
title_sort propofol versus placebo with rescue with ketamine before less invasive surfactant administration study protocol for a multicenter double blind placebo controlled trial prolisa
topic Less invasive surfactant administration
Sedation
Propofol
Ketamine
Randomized study
url http://link.springer.com/article/10.1186/s12887-020-02112-x
work_keys_str_mv AT mariechevallier propofolversusplacebowithrescuewithketaminebeforelessinvasivesurfactantadministrationstudyprotocolforamulticenterdoubleblindplacebocontrolledtrialprolisa
AT xavierdurrmeyer propofolversusplacebowithrescuewithketaminebeforelessinvasivesurfactantadministrationstudyprotocolforamulticenterdoubleblindplacebocontrolledtrialprolisa
AT anneego propofolversusplacebowithrescuewithketaminebeforelessinvasivesurfactantadministrationstudyprotocolforamulticenterdoubleblindplacebocontrolledtrialprolisa
AT thierrydebillon propofolversusplacebowithrescuewithketaminebeforelessinvasivesurfactantadministrationstudyprotocolforamulticenterdoubleblindplacebocontrolledtrialprolisa
AT theprolisastudygroup propofolversusplacebowithrescuewithketaminebeforelessinvasivesurfactantadministrationstudyprotocolforamulticenterdoubleblindplacebocontrolledtrialprolisa